https://orcid.org/0000-0001-5703-3151
Citations (3)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Michael Pichichero, Richard Malley, Ravinder Kaur, Robert Zagursky & Porter Anderson. (2023) Acute otitis media pneumococcal disease burden and nasopharyngeal colonization in children due to serotypes included and not included in current and new pneumococcal conjugate vaccines. Expert Review of Vaccines 22:1, pages 118-138.
Read now
Read now
Articles from other publishers (2)
Ikechukwu Adigweme, Ahmed Futa, Ebrima Saidy-Jah, Bassey Edem, Edem Akpalu, Tida Dibbasey, Vistasp Sethna, Rajeev Dhere, Beate Kampmann, Christopher Bengt, Jake Sirr, Nancy Hosken, David Goldblatt, Kalpana Antony, Mark R Alderson, Steve Lamola & Ed Clarke. (2023) Immunogenicity and safety of a 10-valent pneumococcal conjugate vaccine administered as a 2 + 1 schedule to healthy infants in The Gambia: a single-centre, double-blind, active-controlled, randomised, phase 3 trial. The Lancet Infectious Diseases 23:5, pages 609-620.
Crossref
Crossref
Daniel Jarovsky & Eitan Naaman Berezin. (2023) Impact of PCV10 on pediatric pneumococcal disease burden in Brazil: time for new recommendations?. Jornal de Pediatria 99, pages S46-S56.
Crossref
Crossref